Lineage Cell Therapeutics Inc (LCTX)
1.055
+0.04
(+4.46%)
USD |
NYAM |
May 22, 16:00
1.055
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Price: 1.055 for May 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 21, 2024 | 1.04 | 1.07 | 0.98 | 1.01 | 1.317M |
| May 20, 2024 | 1.07 | 1.08 | 1.02 | 1.04 | 920615.0 |
| May 17, 2024 | 1.08 | 1.09 | 1.020 | 1.08 | 1.361M |
| May 16, 2024 | 1.07 | 1.11 | 1.05 | 1.06 | 732333.0 |
| May 15, 2024 | 1.07 | 1.129 | 1.06 | 1.09 | 979388.0 |
| May 14, 2024 | 1.09 | 1.16 | 1.04 | 1.04 | 2.114M |
| May 13, 2024 | 1.17 | 1.17 | 1.07 | 1.09 | 876496.0 |
| May 10, 2024 | 1.15 | 1.190 | 1.13 | 1.17 | 565962.0 |
| May 09, 2024 | 1.18 | 1.25 | 1.16 | 1.18 | 729223.0 |
| May 08, 2024 | 1.26 | 1.26 | 1.16 | 1.16 | 915518.0 |
| May 07, 2024 | 1.31 | 1.350 | 1.25 | 1.26 | 1.222M |
| May 06, 2024 | 1.07 | 1.400 | 1.07 | 1.30 | 4.103M |
| May 03, 2024 | 1.09 | 1.12 | 1.05 | 1.06 | 614788.0 |
| May 02, 2024 | 1.12 | 1.12 | 1.04 | 1.05 | 1.839M |
| May 01, 2024 | 1.11 | 1.13 | 1.09 | 1.13 | 566216.0 |
| Apr 30, 2024 | 1.12 | 1.15 | 1.08 | 1.09 | 766968.0 |
| Apr 29, 2024 | 1.14 | 1.17 | 1.12 | 1.12 | 428510.0 |
| Apr 26, 2024 | 1.11 | 1.14 | 1.11 | 1.14 | 313340.0 |
| Apr 25, 2024 | 1.10 | 1.14 | 1.10 | 1.11 | 359695.0 |
| Apr 24, 2024 | 1.15 | 1.15 | 1.10 | 1.10 | 747332.0 |
| Apr 23, 2024 | 1.13 | 1.186 | 1.13 | 1.14 | 333219.0 |
| Apr 22, 2024 | 1.14 | 1.17 | 1.12 | 1.14 | 429952.0 |
| Apr 19, 2024 | 1.22 | 1.23 | 1.12 | 1.15 | 1.099M |
| Apr 18, 2024 | 1.30 | 1.30 | 1.18 | 1.20 | 1.041M |
| Apr 17, 2024 | 1.16 | 1.32 | 1.16 | 1.29 | 2.316M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.54
Minimum
Dec 23 2019
3.10
Maximum
Feb 17 2021
1.451
Average
1.31
Median
Feb 06 2020
Price Benchmarks
| Acumen Pharmaceuticals Inc | 3.61 |
| Sarepta Therapeutics Inc | 128.16 |
| CEL-SCI Corp | 1.30 |
| AIM ImmunoTech Inc | 0.382 |
| IGC Pharma Inc | 0.527 |
Price Related Metrics
| PS Ratio | 23.18 |
| Price to Book Value | 2.751 |
| Earnings Yield | -12.32% |
| Market Cap | 199.21M |